Axtria, an agentic AI-first data analytics and cloud software company, and Kedaara Capital, an India-based private equity firm, announced the successful completion of a $240 million transaction.
The transaction is structured as a combination of secondary investment and company-sponsored buyback, and it provides liquidity to Axtria’s current and former employees.
Jaswinder Chadha, President & CEO, Axtria, said, “At Axtria, we are proud to be building a company that is not only transforming life sciences through data and Agentic AI, but also one that values its people and their contributions through long term value creation. Offering liquidity to our current and former employees is a testament to that ethos. In Kedaara, we have found a supportive growth-oriented partner with similar value system and ethos.”
Sunish Sharma, Founder and Managing Partner at Kedaara Capital, said, “At Kedaara, we are committed to backing passionate teams building purpose-driven businesses through relentless execution, creating a positive impact globally. We are delighted to support Axtria’s talented workforce as they continue to scale as a trusted partner, helping life sciences companies harness the power of technology and Agentic AI.”
Aashwit Mahajan, Director and Co-Lead, Technology & Technology Services at Kedaara Capital, said, “Axtria’s combination of industry expertise, technological excellence, and an innovative mindset is not only refreshing but also what truly sets it apart. We look forward to supporting Axtria across organic and inorganic growth opportunities and build on their differentiated value proposition.”
Founded in 2010, Axtria enables efficient, resilient AI-led solutions that help life sciences organizations globally, across the commercial and clinical spectrum. Supporting 18 of the top 20 global pharmaceutical companies and 100+ firms across 75+ countries, Axtria continues to drive growth and innovation. Its newly launched agentic platform, Axtria InsightsMAx.ai™, offers 30+ ready-to-deploy agents, apps, and APIs to move companies from experimentation to scaled AI deployment helping life sciences companies move from experimentation to scaled AI deployment. The Company’s platform portfolio also includes SalesIQ™ for sales excellence, CustomerIQ™ for omnichannel engagement, MarketingIQ™ for marketing analytics, and DataMAx™, which accelerates actionable insights from trusted data sources.
